ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.
Jifeng JiangYifeng SunJiadai XuTianhong XuZhao XuPeng LiuPublished in: Cancer medicine (2020)
Our study showed that ZHX2 can promote proteasome inhibitor resistance in MM cells by regulating the nuclear translocation of NF-κB.